The Harvard Center for Neurodegeneration and Repair has changed its name to the Harvard NeuroDiscovery Center, along with adopting a new tagline: “Collaborating to Cure Neurodegenerative Disease.” The center’s purpose is to transform promising discoveries into effective treatments and cures for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis, ALS, and Huntington’s.
Established in 2001 by Joseph Martin, then dean of HMS, and Dennis Selkoe, the Vincent and Stella Coates professor of neurologic diseases at HMS and BWH, the Harvard NeuroDiscovery Center is a biomedical research collaboration under the direction of Adrian Ivinson. By drawing on the resources of the Harvard Medical community, the center has accelerated the pace of discovery and its translation into prevention and treatment.
To date, the center has engaged more than 600 researchers from across the HMS community and beyond in a portfolio of outcome-directed research programs. Among the center’s initiatives is the Cambridge-based Laboratory for Drug Discovery in Neurodegeneration. Equipped with advanced robotics and a 14-person staff, this facility fills the drug discovery gap between academia and biotechnology and pharmaceutical companies, helping to accelerate the process of turning discoveries into treatments.
For more information about the Harvard NeuroDiscovery Center, visit www.neurodiscovery.harvard.edu.
